 Jerusalem, Israel--Newsfile Corp. - October 18, 2022 - BiondVax Pharmaceuticals Ltd. NASDAQ: BVXV BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, announced today that Joshua Phillipson, BiondVaxs Director of Investor Relations, will attend and present at the LD Micro Main Event XV, an investor conference taking place October 25 to 27, 2022 in Los Angeles. 